Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen while breastfeeding. We will also discuss about common side effects and warnings associated with Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen.

What is Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen used for?


Helps prevent sunburn. If used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun.

Can I continue breastfeeding if I am using Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen? How long does it stays in breast milk?

Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen high risk while breastfeeding
Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen consists two active ingredients Octinoxate and Zinc oxide and as per our analysis of both we have determined the Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen is unsafe during breastfeeding. We recommend you to check both ingredients below for better understanding of Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen in breastfeeding.

Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen Breastfeeding Analsys


Zinc oxide while Breastfeeding

Safe

CAS Number: 1314-13-2

It is used topically as an astringent and skin protector, very often together with small amounts of Ferric Oxide to form Calamine (see specific info). It is a product compatible with breastfeeding according to WHO Essential Medicine’s List - 2002.It is also used in dental hygiene products and cosmetics. Widely used for skin protection of the diaper area in infants. Because of the small dose used and poor absorption into plasma of most topical dermatological preparations, excretion into breastmilk in significant amount appears to be unlikely. Do not apply on the breast to prevent infant ingestion; otherwise, wash it off thoroughly with water before the next breast feed.


Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen Breastfeeding Analsys - 2


Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (500�1000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.


What should I do if already breastfed my kid after using Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen?

We have already established that Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen is unsafe in breastfeeding and breastfeeding while using Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My doctor has prescribed me Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen, what should I do?

If your doctor knows that you are breastfeeding mother and still prescribes Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen then there must be good reason for that as Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Obagi-c Rx System Sun Shield Broad Spectrum Spf 50 Matte Sunscreen in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients